cintake pharmaceutical intermediates co ltd
Agenix Sells HBV Drug To Cinkate For USD$2 Million
With the sale of its patented hepatitis drug AGX-1009 to Cintake, Agenix has exited all operations in China.
With the sale of its patented hepatitis drug AGX-1009 to Cintake, Agenix has exited all operations in China.
